2005
DOI: 10.1016/s0002-9440(10)62963-x
|View full text |Cite
|
Sign up to set email alerts
|

Age-Related Loss of Synaptophysin Immunoreactive Presynaptic Boutons within the Hippocampus of APP751SL, PS1M146L, and APP751SL/PS1M146L Transgenic Mice

Abstract: Neuron and synapse loss are important features of the neuropathology of Alzheimer's disease (AD).Recently, we observed substantial age-related hippocampal neuron loss in APP751 SL /PS1 M146L transgenic mice but not in PS1 M146L mice. Here, we investigated APP751 SL mice, PS1 M146L mice, and APP751 SL / PS1 M146L mice for age-related alterations in synaptic integrity within hippocampal stratum moleculare of the dentate gyrus (SM), stratum lucidum of area CA3 (SL), and stratum radiatum of area CA1-2 (SR) by anal… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

13
73
1

Year Published

2006
2006
2020
2020

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 107 publications
(87 citation statements)
references
References 83 publications
13
73
1
Order By: Relevance
“…Therefore, it is concluded that there is a modification of the density of the tested proteins associated with the vesicular release apparatus which might slightly increase during adulthood and then significantly decreases upon aging. This age-related decrease of presynaptic markers is in general agreement with the majority of studies reporting a decrease in synaptophysin mRNA and protein density and in the number of elements immuno-positive for synaptophysin with aging in the hippocampus and various cortical structures (Chen et al, 1995;Eastwood et al, 1994;Frick and Fernandez, 2003;King and Arendash, 2002;Masliah et al, 1993;Rutten et al, 2005;Saito et al, 1994), albeit some studies reported lack of modification (Calhoun et al, 1998;Eastwood et al, 2006;Nicolle et al, 1999a) and even increases (Benice et al, 2006;Himeda et al, 2005) in the density of this presynaptic marker.…”
Section: Resultssupporting
confidence: 88%
“…Therefore, it is concluded that there is a modification of the density of the tested proteins associated with the vesicular release apparatus which might slightly increase during adulthood and then significantly decreases upon aging. This age-related decrease of presynaptic markers is in general agreement with the majority of studies reporting a decrease in synaptophysin mRNA and protein density and in the number of elements immuno-positive for synaptophysin with aging in the hippocampus and various cortical structures (Chen et al, 1995;Eastwood et al, 1994;Frick and Fernandez, 2003;King and Arendash, 2002;Masliah et al, 1993;Rutten et al, 2005;Saito et al, 1994), albeit some studies reported lack of modification (Calhoun et al, 1998;Eastwood et al, 2006;Nicolle et al, 1999a) and even increases (Benice et al, 2006;Himeda et al, 2005) in the density of this presynaptic marker.…”
Section: Resultssupporting
confidence: 88%
“…This observation was confirmed in 11 cases with stereologic assessment of total amyloid volumes. Also, consistent with recent animal and human studies, our results point to the necessity to explore the effect of Aβ oligomers in AD-related loss of postsynaptic elements (for review see [12,36,37,55]. The relationship between synaptic loss and NFT burden is still a matter of debate.…”
Section: Discussionsupporting
confidence: 86%
“…The semiquantitative results indicated that the density of SIPBs was markedly decreased in the CA3 subfield of the hippocampus in the vehicle-treated APP/PS1 mice compared with the vehicle-treated wild-type controls (Fig. 5 A, B), consistent with a previous report (Rutten et al, 2005). The decreased density of SIPBs was completely reversed in the ATRA-treated APP/PS1 mice compared with the vehicle-treated APP/PS1 mice (Fig.…”
Section: Atra Treatment Attenuates Neurodegeneration In App/ps1 Micesupporting
confidence: 90%
“…Neuronal degeneration and loss observed in the brains of AD patients (West et al, 1994) and in the brains of APP/PS1 transgenic mice (Fonseca et al, 2004;Rutten et al, 2005) is hypothesized to be exacerbated by an inflammatory reaction (McGeer and McGeer, 1999). Given the inhibitory effect of ATRA on glial activation, an indicator of CNS inflammation, we determined the effect of ATRA on neuronal integrity.…”
Section: Atra Treatment Attenuates Neurodegeneration In App/ps1 Micementioning
confidence: 99%